Emerging Markets Grow, U.S. to Fall Short in Global Non-Vascular Stent Market
The device tax, regulatory scrutiny, and a failure to address unmet clinical needs are among the reasons that the United States will fall behind other major markets.
The device tax, regulatory scrutiny, and a failure to address unmet clinical needs are among the reasons that the United States will fall behind other major markets.
Johnson & Johnson holds firm that it will continue to accelerate in the innovation department over the next year.
IBM’s Watson Health Unit is forming several collaborations to facilitate personalized health on a massive scale.
While support services are important, manufacturers must be aware of both state and Federal regulations, as there can be conflicts and differences in interpretations.
The market value for transcatheter heart valves will exceed $3 billion by 2020, and adoption of next-generation valves will drive significant market growth, provided that positive clinical data continues, according to research and consulting firm GlobalData.
Acquisitions and joint ventures with Asian medical companies can provide many advantages for Western firms looking to grow their businesses in Asian medical device markets.
Prior “aggressive” tactics of manufacturers launching new technology can poison the reimbursement environment for a related, but distinct technology occupying the same space. This discussion traces the history of two of the most challenging reimbursement environments: wound healing and spine technologies.
Cardinal CEO George Barrett has said that the company may make more acquisitions in cardiology and endovascular treatment as well as in the trauma and wound care segment.
Uber has taken the struggling, often unloved taxi industry and reinvented it successfully based largely on one premise: Customer is king. In stark contrast, the healthcare industry clearly does not seem to share this mantra.
There are great opportunities for foreign medical device companies in China as the people want better healthcare, the government is increasing access to healthcare, and the market is growing between 15 and 20 percent per year. But access to the marketplace is harder than ever. Why?